ESG

Ero Copper reports record 2025 production and soaring profits, yet a planned slow start to 2026 has investors weighing near-term hurdles against long-term growth.

After its public debut, BBOT unveils exciting early data from three unique cancer drugs, including a first in pancreatic cancer, backed by a strong cash runway.

Weebit Nano's advanced memory is at the heart of a South Korean national program aiming to revolutionize AI with ultra-low-power compute-in-memory chips.

As Galapagos pivots its strategy, it brings in a new HR chief to build the high-performing culture crucial for its next chapter of innovation.

New preclinical data shows Quanta Therapeutics' inhibitors remain potent against cancers that have developed resistance to advanced pan-RAS treatments.

El Pollo Loco is testing five bold new menu items. We dive into the strategy, the competition, and what it means for the fast-casual chicken wars.

GitLab Foundation, with OpenAI, is funding 16 ventures using AI to boost worker incomes, a bold counter-narrative to fears of AI-driven job disruption.

A landmark partnership between Atlas Data Storage and imec aims to commercialize DNA storage, offering a permanent, sustainable solution to the world's data explosion.

A new EU-backed initiative aims to win over UK and Swiss consumers by promoting the health benefits and authenticity of certified extra virgin olive oil.

A new report predicts 3.1 million Ontarians will have a major illness by 2040, revealing regional disparities and straining an already fragile system.

VIO Med Spa is using an advanced training university to standardize excellence, drive rapid franchise growth, and define the future of aesthetic medicine.

Seal Shield's strategic acquisition of Vioguard and its FDA-cleared UV-C tech marks a major step forward in the battle against healthcare-associated infections.

With a new SVP of Global Sales, Slingshot Biosciences is poised to scale its synthetic cell mimic technology, targeting the booming cell therapy market.

A new multi-year deal gives RNAi leader Alnylam access to Helix's vast genomic and clinical data, aiming to redefine the speed of drug discovery.

A new study reveals ER burnout isn't just from long hours, but from chaotic patient intake. Can an AI co-pilot be the antidote for exhausted clinicians?

Sword Health expands its Bloom platform, using AI to offer continuous support for women from fertility to menopause and challenge the fragmented healthcare system.

A new industry-first model allows health plans to pay only for successful HEDIS gap closures, eliminating financial risk amid rising quality pressures.

With a major new investment, Cognito Therapeutics is pushing its non-invasive light and sound therapy for Alzheimer's toward a 2027 market launch.

A new acquisition in data center alley reveals how investors are profiting from the AI boom by betting on the crucial, but overlooked, support infrastructure.

BioRestorative Therapies is leveraging its clinical-grade regenerative medicine to disrupt the aesthetics industry. Can science beat marketing?